Dow Down 0.18% Nasdaq Up 0.39%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.46 Down 0.03(0.40%) Sep 2, 4:00PM EDT
Prev Close:7.49
Open:7.36
Bid:7.15 x 500
Ask:7.50 x 400
1y Target Est:11.33
Beta:2.8
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:7.25 - 7.69
52wk Range:3.84 - 8.46
Volume:1,426,601
Avg Vol (3m):718,534
Market Cap:450.90M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSSDown 0.40%450.90M
AZNDown 1.80%94.27B
PFEDown 0.44%185.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):56.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback